摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-(2-methoxy-2-oxoethoxy)benzoate | 56424-76-1

中文名称
——
中文别名
——
英文名称
methyl 2-(2-methoxy-2-oxoethoxy)benzoate
英文别名
——
methyl 2-(2-methoxy-2-oxoethoxy)benzoate化学式
CAS
56424-76-1
化学式
C11H12O5
mdl
MFCD00854057
分子量
224.213
InChiKey
VSDKPBZNYNNGHH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.272
  • 拓扑面积:
    61.8
  • 氢给体数:
    0
  • 氢受体数:
    5

SDS

SDS:26a3f5301c5a612ceb3a4fb9c3c165fc
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Application of Magnesium Alkoxides to Syntheses of Benzoheterocyclic Compounds
    作者:Jiří Svoboda、Miloslav Nič、Jaroslav Paleček
    DOI:10.1135/cccc19930592
    日期:——

    The Dieckmann condensation of methyl [(2-methoxycarbonyl)phenyl]-X-acetates Ia-Ih (X = O, S, SO2, NH, NCH3) initiated by action of magnesium methoxide, ethoxide, isopropoxide and other basic reagents have been studied under various conditions. Whereas magnesium methoxide has comparable efficiency as sodium methoxide and potassium tert-butoxide in syntheses of benzoheterocyclic compounds IIa-IIh, magnesium ethoxide gives the ethyl ester IIb in medium yield, and magnesium isopropoxide is quite inefficient in the condensation reaction. The alkylation of the esters IIa, IId, and IIg with methyl chloroacetate in the presence of sodium hydride in dimethylformamide gives the diesters IIi - IIk which on action by potassium tert-butoxide undergo the cyclization reaction to give esters III.

    甲基[(2-甲氧羰基)苯基]-X-乙酸酯(X = O,S,SO2,NH,NCH3)在镁甲氧基、乙氧基、异丙氧基和其他碱性试剂的作用下进行的Dieckmann缩合反应在各种条件下进行了研究。镁甲氧基在合成苯杂环化合物方面具有与甲基钠和叔丁基钾相当的效率,而镁乙氧基以中等产率给出乙酸乙酯,镁异丙氧基在缩合反应中效率较低。在二甲基甲酰胺中,酯与氯乙酸甲酯在氢化钠存在下发生烷基化反应,得到二酯,经叔丁基钾作用发生环化反应,生成酯
  • Functionalized drugs and polymers derived therefrom
    申请人:Bezwada S. Rao
    公开号:US20060172983A1
    公开(公告)日:2006-08-03
    Compounds selected from: where DRUG-OH, DRUG-COOH and DRUG-NH 2 are biologically active compounds; each X is independently selected from —CH 2 COO— (glycolic acid moiety), —CH(CH 3 )COO— (lactic acid moiety), —CH 2 CH 2 OCH 2 COO— (dioxanone moiety), —CH 2 CH 2 CH 2 CH 2 CH 2 COO— (caprolactone moiety), —(CH 2 ) y COO—, where y is 2-4 or 6-24 and —(CH 2 CH 2 O) z CH 2 COO—, where z is 2-24; each Y is independently selected from —COCH 2 O— (glycolic ester moiety), —COCH(CH 3 )O— (lactic ester moiety), —COCH 2 OCH 2 CH 2 O— (dioxanone ester moiety), —COCH 2 CH 2 CH 2 CH 2 CH 2 O— (caprolactone ester moiety), —CO(CH 2 ) m O—, where m is 2-4 or 6-24 and —COCH 2 O(CH 2 CH 2 O) n — where n is between 2-24; R′ is hydrogen, benzyl or an alkyl group, the alkyl group being either straight-chained or branched; and p is 1-6. Multi-functional compounds and drug dimers, oligomers and polymers are also disclosed.
    从中选择的化合物:其中DRUG-OH,DRUG-COOH和DRUG-NH2是生物活性化合物;每个X独立地从—CH2COO—(乙二酸基团),—CH(CH3)COO—(乳酸基团),—CH2CH2OCH2COO—(二氧杂环己酮基团),—CH2CH2CH2CH2CH2COO—(己内酯基团),—(CH2)yCOO—中选择,其中y为2-4或6-24和—(CH2CH2O)zCH2COO—,其中z为2-24;每个Y独立地从—COCH2O—(乙二酸酯基团),—COCH(CH3)O—(乳酸酯基团),—COCH2OCH2CH2O—(二氧杂环己酮酯基团),—COCH2CH2CH2CH2CH2O—(己内酯酯基团),—CO(CH2)mO—,其中m为2-4或6-24和—COCH2O(CH2CH2O)n—,其中n为2-24;R′为氢,苄基或烷基,烷基可以是直链或支链;p为1-6。还披露了多功能化合物和药物二聚体、寡聚体和聚合物。
  • FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM
    申请人:Bezwada Rao S.
    公开号:US20090170927A1
    公开(公告)日:2009-07-02
    The present invention relates to compounds of formula I, which are functionalized phenolic compounds, and polymers formed from the same. Ar—[O—(X) p —R′] q I Polymers formed from the functionalized phenolics are expected to have controllable degradation profiles, enabling them to release an active component over a desired time range. The polymers are also expected to be useful in a variety of medical applications.
    本发明涉及公式I的化合物,这些化合物是官能化酚类化合物,以及由它们形成的聚合物。从官能化酚类化合物形成的聚合物预计具有可控的降解特性,使它们能够在所需的时间范围内释放活性成分。这些聚合物还预计在各种医疗应用中有用。
  • Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity
    作者:Aranapakam M. Venkatesan、O. Dos Santos、John Ellingboe、Deborah A. Evrard、Boyd L. Harrison、Deborah L. Smith、Rosemary Scerni、Geoffrey A. Hornby、Lee E. Schechter、Terrence H. Andree
    DOI:10.1016/j.bmcl.2009.12.093
    日期:2010.2
    Several benzofuran derivatives linked to a 3-indoletetrahydropyridine through an alkyl chain were prepared and evaluated for serotonin transporter and 5-HT1A receptor affinities. Their design, synthesis and structure–activity relationships are described.
    制备了几种通过烷基链与3-吲哚四氢吡啶连接的苯并呋喃衍生物,并评估了其血清素转运蛋白和5-HT 1A受体的亲和力。描述了它们的设计,合成和结构-活性关系。
  • Microwave-Assisted Synthesis of Benzofuran-3(2H)-ones
    作者:Xiaojing Hu、Huimin Lai、Fangfei Zhao、Shuyu Hu、Qianqian Sun、Lizhen Fang
    DOI:10.17344/acsi.2019.5104
    日期:——
    A new method for synthesis of benzofuran-3(2H)-one under microwave condition was investigated. The reaction conditon was screened and the eligible scope of benzoate substrates was also examined. It showed that this method could provide a short and facile way to obtain these important dihydrobenzofuranones in yield 43% to 58%.
    研究了微波条件下合成苯并呋喃-3(2H)-一的新方法。筛选反应条件,并检查苯甲酸酯底物的合格范围。结果表明,该方法可以简便快捷地获得这些重要的二氢苯并呋喃酮,收率为43%至58%。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐